Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study suggests immediate statins for heart attack patients

31.08.2004


"Other studies have indicated a benefit for heart attack patients in beginning treatment with statins relatively early, so today the standard practice is to prescribe them upon discharge," says R. Scott Wright, M.D., the Mayo Clinic cardiologist who was the study’s lead investigator in North America. "Our new findings suggest they should be given even earlier, as soon as the patient arrives at the hospital."



The PRINCESS Trial (The PRevention of Ischemic EveNts by Early Treatment of CErivaStatin Study) was designed to test whether very early initiation of statin therapy in hospitalized heart attack patients would prevent deaths and additional heart attacks and reduce the need for bypass surgery or angioplasty.

Within 48 hours of hospitalization, 3,605 patients at 260 medical centers in Europe, Israel, Canada and the United States were randomly assigned to receive either cerivastatin, a potent statin agent, or a placebo. Neither patients nor their physicians knew whether they were receiving the statin or the sugar pill initially, but all of the patients were switched to the statin after three months. Because statins had been proven beneficial as a later-term treatment, withholding the cholesterol-lowering medication for a prolonged period would have been unethical. In the midst of the study, however, cerivastatin’s manufacturer withdrew it from the market due to safety concerns, so the researchers were only able to follow the participants for 4.5 months.


The 1,795 patients initially taking the statin were significantly more likely to reach target levels for LDL (bad) cholesterol, and significantly less likely to have another heart attack or to need surgical or catheter-based interventions to improve blood flow to their hearts during the 4.5 months of follow up.

Dr. Wright says the current study confirms Mayo Clinic’s findings from a retrospective study published in 2001, and indicates that the patient benefits observed are not limited to this particular drug (which is no longer on the market), but are a class effect for statins as a whole. "It is highly unlikely that these results would only apply to cerivastatin, because our previous retrospective study that showed similar benefits involved patients taking a variety of statins," Dr. Wright explains. "By the same token, this broad-based study involving hundreds of hospitals shows that the gains from early statin therapy are not unique to academic medical centers like Mayo Clinic, but can be realized everywhere.

"Physicians should begin treatment of heart attack patients with statins as soon as possible upon admission to the hospital," says Dr. Wright. "And patients should see these results as another reason for them to adhere to the statin therapy prescribed by their physicians."

Lee Aase | EurekAlert!
Further information:
http://www.mayo.edu

More articles from Studies and Analyses:

nachricht Drone vs. truck deliveries: Which create less carbon pollution?
31.05.2017 | University of Washington

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

Im Focus: Optoelectronic Inline Measurement – Accurate to the Nanometer

Germany counts high-precision manufacturing processes among its advantages as a location. It’s not just the aerospace and automotive industries that require almost waste-free, high-precision manufacturing to provide an efficient way of testing the shape and orientation tolerances of products. Since current inline measurement technology not yet provides the required accuracy, the Fraunhofer Institute for Laser Technology ILT is collaborating with four renowned industry partners in the INSPIRE project to develop inline sensors with a new accuracy class. Funded by the German Federal Ministry of Education and Research (BMBF), the project is scheduled to run until the end of 2019.

New Manufacturing Technologies for New Products

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

A rhodium-based catalyst for making organosilicon using less precious metal

22.06.2017 | Materials Sciences

New 3-D display takes the eye fatigue out of virtual reality

22.06.2017 | Information Technology

New technique makes brain scans better

22.06.2017 | Medical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>